Literature DB >> 625667

Value of arterial pressure measurements in the proximal and distal part of the thigh in arterial occlusive disease.

S E Heintz, G E Bone, E E Slaymaker, A C Hayes, R W Barnes.   

Abstract

A prospective study was carried out comparing two techniques of segmental arterial pressure measurements of the leg to detect, localize and quantify regional arterial occlusive disease. The measurement of pressures of the proximal and distal parts of the thigh with the narrow cuff technique permitted correct anatomic localization of aortoiliac, femoropopliteal or combined disease in 78 per cent of diseased extremities, including all limbs with isolated aortoiliac or femoropopliteal disease. A single wide cuff arterial pressure measurement of the thigh correctly localized arterial obstructions in only 19 per cent of diseased extremities. Although a wide cuff is associated with less artifactual elevation in measured arterial pressure at the thigh, this advantage is outweighed by the limitation of diagnostic accuracy in localizing segmental arterial occlusive disease. We recommend that segmental arterial pressure measurements of the limb be made at four levels on the lower extremity, including arterial pressures of the proximal and distal parts of the thigh to achieve maximal diagnostic accuracy.

Entities:  

Mesh:

Year:  1978        PMID: 625667

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  3 in total

1.  Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.

Authors:  Gurbir Dhaliwal; Debabrata Mukherjee
Journal:  Int J Angiol       Date:  2007

2.  The diagnosis of aortoiliac disease. A noninvasive femoral cuff technique.

Authors:  M Barringer; G V Poole; A C Shircliffe; J W Meredith; F Hightower; G W Plonk
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

3.  Patient and operation selectivity. The peripheral vascular laboratory.

Authors:  J M Van De Water; E D Laska; W V Ciniero
Journal:  Ann Surg       Date:  1979-02       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.